QXN · Class II · 21 CFR 874.5400

FDA Product Code QXN: Suction Anti-choking Device As A Second-line Treatment

A Suction Anti-choking Device As A Second-line Treatment Is Intended To Be Used, By Application Of Suction, To Resolve Choking In Victims Experiencing Complete Airway Obstruction. The Device Is Intended To Be Used As A Second-line Treatment In An Emergency Situation After Unsuccessful Use Of A Basic Life Support (bls) Choking Protocol.

Leading manufacturers include Lifevac, LLC.

1
Total
0
Cleared
327d
Avg days
2026
Since
Growing category - 1 submissions in the last 2 years vs 0 in the prior period

FDA 510(k) Cleared Suction Anti-choking Device As A Second-line Treatment Devices (Product Code QXN)

1 devices
1–1 of 1

About Product Code QXN - Regulatory Context

510(k) Submission Activity

1 total 510(k) submissions under product code QXN since 2026, with 0 receiving FDA clearance (average review time: 327 days).

Submission volume has increased in recent years - 1 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.

QXN devices are reviewed by the Ear, Nose, Throat panel. Browse all Ear, Nose, Throat devices →